1. Home
  2. Analysis
  3. Lanoxicaps
  4. Constipation

Lanoxicaps and Constipation - a phase IV clinical study of FDA data

Summary:

Constipation is reported as a side effect among people who take Lanoxicaps (digoxin), especially for people who are female, 60+ old, also take Lasix, and have Cardiac failure congestive.

The phase IV clinical study analyzes which people have Constipation when taking Lanoxicaps. It is created by eHealthMe based on reports of 114 people who have side effects when taking Lanoxicaps from the FDA, and is updated regularly.

What is Lanoxicaps?

Lanoxicaps has active ingredients of digoxin. eHealthMe is studying from 114 Lanoxicaps users. Check the latest studies of Lanoxicaps.

What is Constipation?

Constipation is found to be associated with 3,005 drugs and 4,601 conditions by eHealthMe. Check the latest studies of Constipation.

On Feb, 06, 2026

114 people reported to have side effects when taking Lanoxicaps.
Among them, 14 people (12.28%) have Constipation.

Could Lanoxicaps cause Constipation?

Among these 14 people:

What is the gender of people who have Constipation when taking Lanoxicaps? *

  • female: 92.86 %
  • male: 7.14 %

What is the age of people who have Constipation when taking Lanoxicaps? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 7.69 %
  • 60+: 92.31 %

What are other drugs people take besides Lanoxicaps? *

  1. Lasix: 11 people, 78.57%
  2. Prevacid: 10 people, 71.43%
  3. Fosamax: 10 people, 71.43%
  4. Zaroxolyn: 10 people, 71.43%
  5. Lipitor: 10 people, 71.43%
  6. Zometa: 10 people, 71.43%
  7. Tiazac: 10 people, 71.43%
  8. Clonidine: 3 people, 21.43%
  9. Omega-3 Marine Triglycerides: 3 people, 21.43%
  10. Theophylline: 3 people, 21.43%

What are other side effects people have besides Constipation? *

  1. Multiple Myeloma (cancer of the plasma cells): 10 people, 71.43%
  2. Gastric Disorder (disease of stomach): 10 people, 71.43%
  3. Diabetes: 10 people, 71.43%
  4. Fall: 10 people, 71.43%
  5. Nervousness: 10 people, 71.43%
  6. Psoriasis (immune-mediated disease that affects the skin): 10 people, 71.43%
  7. High Blood Cholesterol: 10 people, 71.43%
  8. Pain: 10 people, 71.43%
  9. Large Intestinal Obstruction: 8 people, 57.14%
  10. Pain In Extremity: 8 people, 57.14%

What are the existing conditions these people have? *

  1. High Blood Pressure: 10 people, 71.43%
  2. High Blood Cholesterol: 10 people, 71.43%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 71.43%
  4. Fluid Retention (an abnormal accumulation of fluid in the blood): 10 people, 71.43%
  5. Cardiac Failure Congestive: 10 people, 71.43%
  6. Osteoporosis (bones weak and more likely to break): 9 people, 64.29%
  7. Blood Potassium Decreased: 7 people, 50.00%
  8. Muscle Spasms (muscle contraction): 3 people, 21.43%
  9. Lung Disorder (lung disease): 3 people, 21.43%
  10. Gout (uric acid crystals building up in the body): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Lanoxicaps and have Constipation?

- Check whether Constipation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lanoxicaps:

Constipation treatments and more:

How severe was Constipation and when was it recovered:

Expand to all the drugs that have ingredients of digoxin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lanoxicaps:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Constipation:

Browse all the conditions that are associated with Constipation:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on digoxin (the active ingredients of Lanoxicaps) and Lanoxicaps (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.